Skip to main content
Top
Published in: BMC Infectious Diseases 1/2018

Open Access 01-12-2018 | Research article

Epidemiology of measles in the metropolitan setting, Addis Ababa, Ethiopia, 2005–2014: a retrospective descriptive surveillance data analysis

Authors: Munira Nasser Hassen, Abyot Bekele Woyessa, Mekonen Getahun, Berhane Beyene, Lucy Buluanger, Ayesheshem Ademe, Alemayehu Bekele, Adamu Addissie, Amha Kebede, Daddi Jima

Published in: BMC Infectious Diseases | Issue 1/2018

Login to get access

Abstract

Background

Measles is a highly infectious and serious respiratory viral disease which caused by a virus. It is a significant cause of illness and death worldwide. This data analysis was conducted to describe the trend and determine the reporting rate of measles cases in Addis Ababa to make recommendation for the government of the city to strengthening measles control interventions.

Methods

We obtained and extracted ten years (2005–2014) Addis Ababa city’s measles surveillance data from national database. We carried out retrospective descriptive data analysis by time, place and person variables. We calculated cumulative and specific reporting rates by dividing measles cases (lab confirmed, epidemiologically linked and compatible cases) to respective population and multiplying by 100,000. We divided average of ten years measles cases to midyear population and multiplied by 100,000 to calculate annualized reporting rate. We analyzed non-measles febrile rash rate by dividing laboratory negative cases to total population and multiplying by 100,000.

Results

A total of 4203 suspected measles cases were identified. Among them 1154 (27.5%) were laboratory confirmed, 512 (12.2%) were clinically compatible, 52 (1.2%) were epidemiologically linked cases and the rest 2485 (59.1%) were IgM negative for measles which makes total measles cases 1718 (40.9%). Median age was 5 years with 2–18 years interquartile-range. The annualized measles reporting rate was 5.9, which was 40.2 among > 1 year, 11.5 among 1–4 years, 6.0 among 5–14 years, 4.1 among 15–44 years and 0.01 among ≥ 45 years per 100,000 population. Among the total measles cases; 380 (22%) were received at least one dose of measles containing vaccine (MCV) while 415 (24%) cases were not vaccinated and the vaccination status of 923 (54%) cases were not known.

Conclusion

Our analysis revealed that the reporting rate was higher among young children than older age group. Among all the patients 22% were received at least one dose of measles vaccine whereas 13% were not vaccinated against measles antigen. Routine immunization should be strengthened to reach all children through well monitored vaccine cold chain management.
Literature
1.
go back to reference Gastanaduy Paul A, Redd Susan B, Clemmons Nakia S, Lee Adria D, Hickman Carole J, Rota Paul A, Patel M. Chapter 7: Measles. In: CDC Surveill Man; 2017. p. 1–21. Gastanaduy Paul A, Redd Susan B, Clemmons Nakia S, Lee Adria D, Hickman Carole J, Rota Paul A, Patel M. Chapter 7: Measles. In: CDC Surveill Man; 2017. p. 1–21.
2.
go back to reference Coughlin MM, Beck AS, Bankamp B, Rota PA. Perspective on global measles epidemiology and control and the role of novel vaccination strategies. Viruses. 2017;9:1.CrossRef Coughlin MM, Beck AS, Bankamp B, Rota PA. Perspective on global measles epidemiology and control and the role of novel vaccination strategies. Viruses. 2017;9:1.CrossRef
3.
go back to reference Public Health Agency of Canada. Guidelines for the Prevention and Control of Measles Outbreaks in Canada. In: Vol. 39, Canada Communicable Disease Report; 2013. p. 1–52. Public Health Agency of Canada. Guidelines for the Prevention and Control of Measles Outbreaks in Canada. In: Vol. 39, Canada Communicable Disease Report; 2013. p. 1–52.
4.
go back to reference Measles M, Region E, Rubella R, Mumps M. Vaccine-preventable diseases: Signs , symptoms & complications. 2012. Measles M, Region E, Rubella R, Mumps M. Vaccine-preventable diseases: Signs , symptoms & complications. 2012.
5.
go back to reference Kutty P, Rota J, Bellini W, Redd SB, Albert Barskey GW. Measles. In: VPD Surveillance Manual. 6th ed; 2013. p. 1–21. Kutty P, Rota J, Bellini W, Redd SB, Albert Barskey GW. Measles. In: VPD Surveillance Manual. 6th ed; 2013. p. 1–21.
6.
go back to reference Katz SL, Gellin BG. Measles vaccine: do we need new vaccines or new programs? Science (80-). 1994;265(5177):1391–2.CrossRef Katz SL, Gellin BG. Measles vaccine: do we need new vaccines or new programs? Science (80-). 1994;265(5177):1391–2.CrossRef
8.
9.
go back to reference Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). Mmwr. 2013;62(4):1–34. Centers for Disease Control and Prevention. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). Mmwr. 2013;62(4):1–34.
11.
go back to reference Goodson JL, Masresha BG, Wannemuehler K, Uzicanin A, Cochi S. Changing epidemiology of measles in Africa. J Infect Dis. 2011;204(SUPPL. 1):205–14.CrossRef Goodson JL, Masresha BG, Wannemuehler K, Uzicanin A, Cochi S. Changing epidemiology of measles in Africa. J Infect Dis. 2011;204(SUPPL. 1):205–14.CrossRef
12.
go back to reference Patel MK, Gacic-dobo M, Strebel PM, Dabbagh A, Mulders MN. Progress Toward Regional Measles Elimination. Worldwide, 2000–2015. 2016;65(44):1228–33. Patel MK, Gacic-dobo M, Strebel PM, Dabbagh A, Mulders MN. Progress Toward Regional Measles Elimination. Worldwide, 2000–2015. 2016;65(44):1228–33.
13.
go back to reference Ethiopian Public Health Institute. Guideline on measles surveillance and outbreak management. 3rd ed. Addis Ababa: Ethiopian Public Health Institute; 2012. p. 6–8. Ethiopian Public Health Institute. Guideline on measles surveillance and outbreak management. 3rd ed. Addis Ababa: Ethiopian Public Health Institute; 2012. p. 6–8.
14.
go back to reference Mitiku K, Bedada T, Masresha BG, Kegne W, Nafo-Traore F, Neghist Tesfaye AY. Progress in measles mortality reduction in Ethiopia, 2002-2009. JID. 2011;204(Suppl 1):232–8.CrossRef Mitiku K, Bedada T, Masresha BG, Kegne W, Nafo-Traore F, Neghist Tesfaye AY. Progress in measles mortality reduction in Ethiopia, 2002-2009. JID. 2011;204(Suppl 1):232–8.CrossRef
15.
go back to reference WHO/UNICEF/FMOH. Ethiopian National Expanded Programme on Immunization: Comprehensive Multi-Year Plan 2011–2015. Addis Ababa: FMOH; 2010. WHO/UNICEF/FMOH. Ethiopian National Expanded Programme on Immunization: Comprehensive Multi-Year Plan 2011–2015. Addis Ababa: FMOH; 2010.
21.
go back to reference Altizer S, Dobson A, Hosseini P, Hudson P, Pascual M. REVIEWS AND seasonality and the dynamics of infectious diseases. Ecol Lett. 2006;9:467–84.CrossRefPubMed Altizer S, Dobson A, Hosseini P, Hudson P, Pascual M. REVIEWS AND seasonality and the dynamics of infectious diseases. Ecol Lett. 2006;9:467–84.CrossRefPubMed
22.
go back to reference Dollimore N, Cutts F, Binka FN, Ross DA, Morris SS, Smith PG. Measles incidence, case fatality, and delayed mortality in children with or without vitamin a supplementation in rural Ghana. Am J Epidemiol. 1997;146(8):646–54.CrossRefPubMed Dollimore N, Cutts F, Binka FN, Ross DA, Morris SS, Smith PG. Measles incidence, case fatality, and delayed mortality in children with or without vitamin a supplementation in rural Ghana. Am J Epidemiol. 1997;146(8):646–54.CrossRefPubMed
24.
go back to reference Wolfson LJ, Grais RF, Luquero FJ, Birmingham ME, Strebel PM. Estimates of measles case fatality ratios: a comprehensive review of community-based studies. Int J Epidemiol. 2009;38(1):192–205.CrossRefPubMed Wolfson LJ, Grais RF, Luquero FJ, Birmingham ME, Strebel PM. Estimates of measles case fatality ratios: a comprehensive review of community-based studies. Int J Epidemiol. 2009;38(1):192–205.CrossRefPubMed
25.
go back to reference Minetti A, Kagoli M, Katsulukuta A, Huerga H, Featherstone A, Chiotcha H, et al. Lessons and challenges for measles control from unexpected large outbreak. Malawi Emerg Infect Dis. 2013;19(2):202–9.CrossRefPubMed Minetti A, Kagoli M, Katsulukuta A, Huerga H, Featherstone A, Chiotcha H, et al. Lessons and challenges for measles control from unexpected large outbreak. Malawi Emerg Infect Dis. 2013;19(2):202–9.CrossRefPubMed
26.
go back to reference Enquselassie F, Ayele W, Dejene A, Messele T, Abebe A, Cutts FT, et al. Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination. Epidemiol Infect. 2003;130(3):507–19.PubMedPubMedCentral Enquselassie F, Ayele W, Dejene A, Messele T, Abebe A, Cutts FT, et al. Seroepidemiology of measles in Addis Ababa, Ethiopia: implications for control through vaccination. Epidemiol Infect. 2003;130(3):507–19.PubMedPubMedCentral
27.
go back to reference Sudfeld CR, Navar AM, Halsey NA. Effectiveness of measles vaccination and vitamin a treatment. Int J Epidemiol. 2010;39(SUPPL. 1):48–55.CrossRef Sudfeld CR, Navar AM, Halsey NA. Effectiveness of measles vaccination and vitamin a treatment. Int J Epidemiol. 2010;39(SUPPL. 1):48–55.CrossRef
28.
Metadata
Title
Epidemiology of measles in the metropolitan setting, Addis Ababa, Ethiopia, 2005–2014: a retrospective descriptive surveillance data analysis
Authors
Munira Nasser Hassen
Abyot Bekele Woyessa
Mekonen Getahun
Berhane Beyene
Lucy Buluanger
Ayesheshem Ademe
Alemayehu Bekele
Adamu Addissie
Amha Kebede
Daddi Jima
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2018
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-018-3305-4

Other articles of this Issue 1/2018

BMC Infectious Diseases 1/2018 Go to the issue